Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Revumenib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,631Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Syndax's Positive Revuforj® Data in Relapsed/Refractory mNPM1 AML
    Syndax's Positive Revuforj® Data in Relapsed/Refractory mNPM1 AML

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/syndax-announces-additional-positive-data-for-revuforj-revumenib-from-augment-101-trial-in-relapsed-or-refractory-mnpm1-aml-and-beat-aml-frontline-combination-trial-302325675.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share
    Syndax's Revuforj® Data Positive In Acute Leukemias Trials
    Syndax's Revuforj® Data Positive In Acute Leukemias Trials

    07 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/syndax-presents-positive-revuforj-revumenib-data-in-acute-leukemias-from-multiple-trials-including-the-save-combination-and-augment-101-trials-at-66th-ash-annual-meeting-302325478.html

    PR NEWSWIRE
    07 Dec 2024
    Share Share
    Onco360 Selected As Specialty Pharmacy Partner For Revuforj
    Onco360 Selected As Specialty Pharmacy Partner For Revuforj

    20 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/20/2984797/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-Revuforj-revumenib.html

    GLOBENEWSWIRE
    20 Nov 2024
    Share Share
    US FDA approves Syndax's blood cancer drug
    US FDA approves Syndax's blood cancer drug

    16 Nov 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-syndaxs-blood-cancer-drug-2024-11-15/

    REUTERS
    16 Nov 2024
    Share Share
    Syndax Publishes AUGMENT-101 Trial Data On Revumenib In Leukemia
    Syndax Publishes AUGMENT-101 Trial Data On Revumenib In Leukemia

    12 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/syndax-announces-publication-in-the-journal-of-clinical-oncology-of-data-from-the-pivotal-augment-101-trial-of-revumenib-in-relapsedrefractory-kmt2ar-acute-leukemia-302219402.html

    PR NEWSWIRE
    12 Aug 2024
    Share Share
    Syndax Announces PDUFA Date Extension For Revumenib In Acute Leukemia
    Syndax Announces PDUFA Date Extension For Revumenib In Acute Leukemia

    29 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/syndax-announces-pdufa-action-date-extension-for-revumenib-nda-for-relapsed-or-refractory-kmt2ar-acute-leukemia-302208308.html

    PR NEWSWIRE
    29 Jul 2024
    Share Share